Our client, a top 5 pharmaceutical company, was facing an expected volume increase to their portfolio of between 45,000 – 55,000 submissions per annum. With their mandate to accommodate the growth without increasing cost and ensuring there was no disruption to the business and no slip in either quality or timeframe, they engaged with us as their regulatory outsourcing partner.
Complete the form to download our case study and learn how Navitas Life Sciences have successfully provided submission management, publishing, and product license support to our client for the past nine years. Our client is benefiting from:
- Successful delivery of an annual average of 15,000 – 18,000 First-Time-Right submissions
- 100% conformance to submission timelines
- 100% SLA adherence
- 30% efficiency gain over baseline